← SynDRA
Tsr-011
SynDRA canonical compound SYN0044922 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ALK | NTRK1 | NTRK2 | NTRK3 |
|---|
| Mechanism of action | receptor tyrosine protein kinase inhibitor |
|---|
All known targets
- ALK
- AXL
- FLT3
- IRAK1
- LCK
- LTK
- MAP4K2
- MERTK
Mechanisms of action (all sources)
- ALK INHIBITOR
- AXL INHIBITOR
- FLT3 INHIBITOR
- IRAK1 INHIBITOR
- LCK INHIBITOR
- LTK INHIBITOR
- MERTK INHIBITOR
- MAP4K2 INHIBITOR
Cross-references
Synonyms
- Belizatinib
- RefChem:933606
- ALK/TRK Inhibitor TSR-011
- Belizatinib (TSR011)
- Belizatinib [INN]
- Belizatinib [WHO-DD]
- Belizatinib (TSR-011)
- TSR011
- Z8A6022P3J
- Belizatinib(TSR-011)
- Belizatinib(TSR-011)?
- Belizatinib [INN:WHO-DD]
- SCHEMBL573248
- SCHEMBL573249
- SCHEMBL573250
- SCHEMBL573251
- UNII-Z8A6022P3J
- orb1303016
- SCHEMBL19328243
- SCHEMBL19328244
- SCHEMBL21206279
- SCHEMBL24046243
- C33H44FN5O3
- GTPL10474
- BDBM513991
- GLXC-10675
- EX-A1509
- BDBM50396243
- s8511
- AKOS037648708
- CCG-270116
- CS-6943
- EBC-220189
- compound 36 [PMID: 22734674]
- NCGC00510695-02
- US11059827, Compound TSR-011
- AC-33658
- BS-15301
- BT166430
Look up Tsr-011 in the interactive SynDRA portal →